Inventor

KREFT ANTHONY

US23 patents

⚠️ This page may combine multiple inventors who share the name “KREFT ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KREFT ANTHONY

ELAN PHARM INC

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4

Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

WYETH CORP

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors

(unassigned)

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

ATHENA NEUROSCIENCES INC

Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4